Neue Suche | Kongressdetail

PI3K Pathways Summit 2021

Evvnt Promotion / evvnt

Archiv

24.08.2021 - 26.08.2021 Online

Time: 9:00 am - 5:00 pm

Kongressthemen
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/783356-3?pid=4832

Speakers: Zoe Johnson, Chief Scientific Officer, iOnctura, James Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics and more

Anfragen und Anmeldung:

https://go.evvnt.com/783356-0?pid=4832

Frau Anita Kelemen

161 07455 4188

info@hansonwade.com

Kategorien
Allgemeinmedizin, Onkologie

Sprache
Englisch

Website
go.evvnt.com/783356-2?pid=4832

Kongressgebühr
USD 1349.00 - USD 3397.00

Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien

Tel: +44 0207 3230 450
hello@evvnt.com

evvnt.com/